Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23K Buy
8,210
+1,018
+14% +$2.94K ﹤0.01% 1619
2026
Q1
$18K Sell
7,192
-2,384
-25% -$7.68K ﹤0.01% 1645
2025
Q4
$29.5K Sell
9,576
-1,562
-14% -$5.36K ﹤0.01% 1429
2025
Q3
$40.4K Sell
11,138
-2,177
-16% -$8.27K ﹤0.01% 1233
2025
Q2
$55.9K Buy
+13,315
New +$52.2K ﹤0.01% 1080

Other funds holding EVO

UMB Bank's EVO Position: Q2 2026 in Review

UMB Bank increased its Evotec (EVO) stake by 14% in Q2 2026, buying an estimated $2.94K and bringing the position to 8,210 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

UMB Bank first reported a position in EVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $55.9K in Q2 2025. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

  • UMB Bank held 8,210 shares of Evotec worth $23K as of Q2 2026.
  • UMB Bank bought 1,018 Evotec shares in Q2 2026, an estimated $2.94K.
  • Evotec made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1619 holding.
  • UMB Bank first reported a position in Evotec in Q2 2025 and has held it in 5 quarters since.
  • UMB Bank's Evotec position peaked at $55.9K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.